Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers: Insights Derived From the FOURIER Trial
| Publication | Article in JAMA Cardiology, published December 2017 |
|---|---|
| Authors | Alejandro Arrieta, Jonathan C. Hong, Rohan Khera, Salim S. Virani, Harlan M. Krumholz, Khurram Nasir |
This is the public page for a publication record in Dimensions, a free research insights platform that brings together information about funding, scholarly outputs, policy, patents and grants.
Loading metrics…